Focused Wealth Management, Inc Invitae Corp Transaction History

Focused Wealth Management, Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$1.9 - $8.63 $12,730 - $57,821	6,700 Added 34.9%	25,900 $64,000
Q2 2022 Aug 04, 2022	SELL	$2.13 - $9.01 $745 - $3,153	-350 Reduced 1.79%	19,200 $47,000
Q1 2022 Apr 29, 2022	BUY	$6.28 - $15.59 $3,140 - $7,795	500 Added 2.62%	19,550 $156,000
Q4 2021 Jan 31, 2022	SELL	$14.7 - $28.67 $142,590 - $278,099	-9,700 Reduced 33.74%	19,050 $291,000
Q3 2021 Oct 12, 2021	SELL	$24.31 - $33.6 $9,724 - $13,440	-400 Reduced 1.37%	28,750 $817,000

Q2 2021 Jul 15, 2021	BUY	$26.09 - $40.4 $6,522 - $10,100	250 Added 0.87%	29,150 $983,000
Q1 2021 May 03, 2021	BUY	$33.06 - $56.93 $3,306 - $5,693	100 Added 0.35%	28,900 $1.1 Million
Q4 2020 Feb 03, 2021	SELL	$39.09 - $57.4 $4,495 - $6,601	-115 Reduced 0.4%	28,800 $1.2 Million
Q3 2020 Oct 19, 2020	SELL	$28.43 - $44.67 $18,991 - $29,839	-668 Reduced 2.26%	28,915 $1.25 Million
Q2 2020 Jul 24, 2020	SELL	$11.71 - $30.29 $9,250 - $23,929	-790 Reduced 2.6%	29,583 $896,000
Q1 2020 May 06, 2020	SELL	$7.64 - $27.5 $39,842 - $143,412	-5,215 Reduced 14.65%	30,373 $415,000
Q4 2019 Jan 21, 2020	SELL	$15.02 - $20.57 $25,308 - $34,660	-1,685 Reduced 4.52%	35,588 $574,000
Q3 2019 Nov 06, 2019	BUY	$18.85 - $27.5 $102,732 - $149,875	5,450 Added 17.13%	37,273 $718,000
Q2 2019 Jul 19, 2019	BUY	$17.37 - $26.27 $18,238 - $27,583	1,050 Added 3.41%	31,823 $748,000
Q1 2019 May 03, 2019	BUY	$10.65 - $25.75 $242,532 - $586,404	22,773 Added 284.66%	30,773 $721,000
Q4 2018 Jan 30, 2019	BUY	$9.26 - $16.38 $74,080 - $131,039	8,000 New	8,000 $88,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.